FNY Investment Advisers’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

FNY Investment Advisers’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,838	Closed	-$28	–	880
2024 Q1	$28	Buy	+5,838	New	+$29.3K	0.02%	328
2019 Q4	–	Sell	-478	Closed	-$33K	–	1110
2019 Q3	$33K	Buy	478 +175	+58%	+$17.8K	0.01%	449
2019 Q2	$37K	Sell	303 -370	-55%	-$54.7K	0.01%	405
2019 Q1	$111K	Buy	673 +13	+2%	+$1.94K	0.04%	242
2018 Q4	$104K	Buy	+660	New	+$148K	0.04%	177

Other funds holding ASLN

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

FNY Investment Advisers's ASLN Position: Q2 2024 in Review

FNY Investment Advisers sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q2 2024, closing a stake of 5,838 shares — an estimated $28 sold.

FNY Investment Advisers first reported a position in ASLN in Q4 2018 and held it in 5 quarters. The position peaked at $111K in Q1 2019. 19 funds tracked by Wall St. Rank hold ASLN as of Q2 2024.

FNY Investment Advisers reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q2 2024 after selling out during the quarter.
FNY Investment Advisers sold 5,838 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q2 2024, an estimated $28.
FNY Investment Advisers first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2018 and held it in 5 quarters.
FNY Investment Advisers's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $111K in Q1 2019.
19 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q2 2024.

Based on FNY Investment Advisers's 13F filing for Q2 2024, filed 5 Aug 2024.